Isis Pharmaceuticals Inc. (ISIS) Stock Quote

Detailed Quote for Isis Pharmaceuticals Inc. (ISIS)

After Hours: $ 8.34

0.01 (+0.12%)

Volume: 236

4:27 PM EST Feb 10, 2012

close 52 Week Information

52 Week High

February 28, 2011

Close: 9.61

52 Week Low

October 4, 2011

Close: 6.25

Today

Last Price
8.33

Change $
0.26

Change %
3.03%

Tick
N/A

Bid
N/A

Bid Size
0

Ask
N/A

Ask Size
0

Open
8.50

High
8.559

Low
8.30

Prev Close
8.59

Last Trade
2/10/12

Volume
375.05 k

52 Wk Hi
9.61

52 Wk Low
6.25

Market Cap
830.75 m

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
99,729,321

EPS (TTM)
-0.79

PE Ratio
N/A

close Exchange Information Listed On Nasdaq Global Select (NGS) Exchange
NGS

News and Media for Isis Pharmaceuticals Inc. (ISIS)

Sector News | Topic News

News for ISIS

Wed, Feb 08, 2012

7:00 AM

Isis Pharmaceuticals to Present at Leerink Swann's 2012 Global Healthcare Conference - PR Newswire

Thu, Jan 05, 2012

10:47 AM

Webcast Alert: Isis Pharmaceuticals Announces Its R&D Webcast Presentation - PR Newswire

8:00 AM

ISIS Reports Phase 1 Data Demonstrating ISIS-TTRRx Produces Significant Reductions in TTR Protein - PR Newswire

8:00 AM

Regulus Therapeutics to Present microRNA Platform and Pipeline Updates at Two Leading Scientific Conferences - PR Newswire

Wed, Jan 04, 2012

8:30 AM

Biogen Idec and Isis Pharmaceuticals Announce Global Collaboration for Antisense Program Targeting Spinal Muscular Atrophy - Business Wire

Tue, Dec 20, 2011

12:00 PM

Webcast Alert: Isis Pharmaceuticals Announces Its R&D Webcast Presentation - PR Newswire

8:00 AM

Isis Initiates Phase 1 Clinical Trial of ISIS-FGFR4Rx a Peripherally Acting Drug to Treat Obesity - PR Newswire

Mon, Dec 19, 2011

8:00 AM

Isis Initiates Phase 1 Clinical Study of ISIS-SMNRx in Patients With Spinal Muscular Atrophy - PR Newswire

Thu, Dec 15, 2011

8:00 AM

Isis Updates KYNAMRO Submission Timeline - PR Newswire

Wed, Dec 14, 2011

7:12 PM

Isis Adds Three New Drugs to Its Development Pipeline - PR Newswire

Mon, Dec 12, 2011

11:00 AM

Isis Reports Positive Phase 1 Data Demonstrating ISIS-FXIRx Reduces Factor XI Activity Without Bleeding - PR Newswire

8:00 AM

Regulus Therapeutics Initiates an Orphan and Rare Disease microRNA Therapeutic Effort in Brain Cancer - PR Newswire

Thu, Dec 08, 2011

7:00 AM

Webcast Alert: Isis Pharmaceuticals Holds Webcast to Discuss Recent Additions to its Development Pipeline - PR Newswire

Tue, Dec 06, 2011

8:00 AM

Isis Reports Positive Phase 1 Data Demonstrating ISIS-APOCIIIRx Produces Significant Reductions in apoC-III Protein Levels and Triglycerides - PR Newswire

Wed, Nov 30, 2011

7:15 AM

United States Patent and Trademark Office Upholds Key Santaris Pharma A/S LNA Patents in Two Re-Examination Cases Brought by Isis Pharmaceuticals - PR Newswire

Wed, Nov 23, 2011

7:00 AM

Isis Pharmaceuticals to Present at the 23rd Annual Piper Jaffray Health Care Conference - PR Newswire

Tue, Nov 22, 2011

7:30 AM

Isis to Receive Up to $14 Million from Pfizer for Its Acquisition of Excaliard Pharmaceuticals - PR Newswire

Tue, Nov 08, 2011

8:00 AM

Regulus Therapeutics to Present New In Vivo Data for microRNA-21 in Kidney Fibrosis - PR Newswire

Mon, Nov 07, 2011

4:00 PM

Isis Reports Financial Results and Highlights for Third Quarter 2011 - PR Newswire

Wed, Nov 02, 2011

7:00 AM

Isis Initiates Phase 1 Studies with Isis-GCGRRx and Isis-GCCRRx to Treat Type 2 Diabetes - PR Newswire

More News for ISIS >>

Tags for Isis Pharmaceuticals Inc.

Research stocks or mutual funds related to Isis Pharmaceuticals Inc. by keywords or tags. Find companies that have a similar focus to ISIS. The keywords below have been associated to ISIS by either user submission or electronic means.

biotechnology company counselor employment aventis pharmaceuticals clinical trials database pharmaceuticals research pharmaceuticals international research clinical trials liability fashion employment clinical research trial employment classifieds clinical trials data pharmaceutical market Commercial Physical And Biological Research (8731) pharmaceuticals clinical trials pharmaceuticals companies generic pharmaceutical pharmaceuticals logistics niche pharmaceutical investor relations consultants pharmaceuticals careers clinical pharmacology europe pharmaceuticals pharmaceutical research and development clinical research training dupont pharmaceuticals school nurse employment pharmaceuticals germany pharma manufacturing webcasts medical research company safeway employment pharmaceuticals jobs webcast isis band pfizer pharmaceutical company phase iii clinical trials romania clinical research novartis pharmaceuticals pharmaceuticals supply chain warrick pharmaceutical clinical research enrollment clinical trials pharmaceutical cro pharma companies isis pants isis statue investor relations data jobs in construction employment testing pharmaceutical sales